FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marvin Grubman

Research Profile

Disorders

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Virus Replication

Co-author Network

Publications

TOP 3
Fayna Diaz-San Segundo; Max Custer; Teresa de los Santos; Camila C A Dias; Kurt I Kamrud; Mauro P Moraes; Gary Owens; Eva Perez-Martin; Marcelo Weiss; Marvin J Grubman
Venezuelan Equine Encephalitis Replicon Particles Can Induce Rapid Protection against Foot-and-Mouth Disease Virus.
Diana M Alejo; Camila C Dias; Marvin J Grubman; Xiaofen Liao; Mauro P Moraes; Debra Rood; Edan R Tulman; Fayna Diaz-San Segundo; Lawrence K Silbart
An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.
Camila C Dias; Mauro P Moraes; Eva Perez-Martin; Andres M Salazar; Marcelo Weiss; Teresa de los Santos; Fayna Diaz-San Segundo; Marvin J Grubman
Novel antiviral therapeutics to control foot-and-mouth disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marvin Grubman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Fayna Diaz-San Segundo; Max Custer; Teresa de los Santos; Camila C A Dias; Kurt I Kamrud; Mauro P Moraes; Gary Owens; Eva Perez-Martin; Marcelo Weiss; Marvin J Grubman
Venezuelan Equine Encephalitis Replicon Particles Can Induce Rapid Protection against Foot-and-Mouth Disease Virus.
Journal of virology 2013;87(10):5447-60.
2013: Diana M Alejo; Camila C Dias; Marvin J Grubman; Xiaofen Liao; Mauro P Moraes; Debra Rood; Edan R Tulman; Fayna Diaz-San Segundo; Lawrence K Silbart
An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.
Vaccine 2013;31(18):2302-9.
2012: Camila C Dias; Mauro P Moraes; Eva Perez-Martin; Andres M Salazar; Marcelo Weiss; Teresa de los Santos; Fayna Diaz-San Segundo; Marvin J Grubman
Novel antiviral therapeutics to control foot-and-mouth disease.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2012;32(10):462-73.
2012: Susan L Brockmeier; Douglas E Brough; Marvin J Grubman; Crystal L Loving; Laura C Miller; Eric A Nelson; Tracy L Nicholson; Karen B Register; Marcus E Kehrli
The presence of alpha interferon at the time of infection alters the innate and adaptive immune responses to porcine reproductive and respiratory syndrome virus.
Clinical and vaccine immunology : CVI 2012;19(4):508-14.
2012: Eva Perez-Martin; Marcelo Weiss; Jonathan Arzt; Fayna Diaz-San Segundo; Marvin J Grubman; Juan M Pacheco; Teresa de los Santos
Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle.
Journal of virology 2012;86(8):4477-87.
2012: Fayna Díaz-San Segundo; Camila C Dias; Marvin J Grubman; Eva Pérez-Martín; Marcelo Weiss; Teresa de los Santos
Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease.
Journal of virology 2012;86(3):1316-27.
2011: Mauro P Moraes; Lindomar Pena; Fayna Diaz-San Segundo; Camila C Dias; Marvin J Grubman
Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
Vaccine 2011;29(51):9431-40.
2011: J Arzt; Barry Baxt; Marvin J Grubman; T Jackson; N Juleff; J Rhyan; E Rieder; R Waters; Luis L Rodriguez
The pathogenesis of foot-and-mouth disease II: viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions.
Transboundary and emerging diseases 2011;58(4):305-26.
2011: William T Golde; Marvin J Grubman; L Robinson; N Sevilla; Artur Summerfield; T de Los Santos; B Charleston
Evidence of activation and suppression during the early immune response to foot-and-mouth disease virus.
Transboundary and emerging diseases 2011;58(4):283-90.
2011: Fayna Díaz-San Segundo; Marcelo Weiss; Eva Perez-Martín; Marla Koster; James Zhu; Marvin J Grubman; Teresa de los Santos
Antiviral activity of bovine type III interferon against foot-and-mouth disease virus.
Virology 2011;413(2):283-92.
2011: Jared R Patch; Lasse E Pedersen; Felix Toka; Mauro Moraes; Marvin J Grubman; Morten Nielsen; Gregers Jungersen; Soren Buus; William T Golde
Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination.
Clinical and vaccine immunology : CVI 2011;18(2):280-8.
2011: Camila C A Dias; Mauro P Moraes; Fayna Diaz-San Segundo; Teresa de los Santos; Marvin J Grubman
Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2011;31(2):227-36.
2010: James Zhu; Marcelo Weiss; Marvin J Grubman; Teresa de los Santos
Differential gene expression in bovine cells infected with wild type and leaderless foot-and-mouth disease virus.
Virology 2010;404(1):32-40.
2010: Fayna Diaz-San Segundo; Mauro P Moraes; Teresa de los Santos; Camila C A Dias; Marvin J Grubman
Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression.
Journal of virology 2010;84(4):2063-77.
2009: Luis L Rodriguez; Marvin J Grubman
Foot and mouth disease virus vaccines.
Vaccine 2009;27 Suppl 4():D90-4.
2009: Teresa de los Santos; Fayna Diaz-San Segundo; James Zhu; Marla Koster; Camila C A Dias; Marvin J Grubman
A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function.
Journal of virology 2009;83(4):1800-10.
2008: Gregory J Tobin; Jessie D Trujillo; Ruth V Bushnell; George Lin; A Ray Chaudhuri; Jinxue Long; Jose Barrera; Lindomar Pena; Marvin J Grubman; Peter L Nara
Deceptive imprinting and immune refocusing in vaccine design.
Vaccine 2008;26(49):6189-99.
2008: Lindomar Pena; Mauro Pires Moraes; Marla Koster; Thomas G Burrage; Juan M Pacheco; Fayna Diaz-San Segundo; Marvin J Grubman
Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
Vaccine 2008;26(45):5689-99.
2008: Marvin J Grubman; Mauro Pires Moraes; Fayna Diaz-San Segundo; Lindomar Pena; Teresa de los Santos
Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen.
FEMS immunology and medical microbiology 2008;53(1):8-17.
2007: Teresa de los Santos; Fayna Diaz-San Segundo; Marvin J Grubman
Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection.
Journal of virology 2007;81(23):12803-15.
2007: Mauro P Moraes; Teresa de los Santos; Marla Koster; Traci Turecek; He Wang; Vladimir G Andreyev; Marvin J Grubman
Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.
Journal of virology 2007;81(13):7124-35.
2006: Sonia de Avila Botton; Mario C S Brum; Elida M Bautista; Marla Koster; Rudi Weiblen; William T Golde; Marvin J Grubman
Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.
Vaccine 2006;24(17):3446-56.
2006: Teresa de los Santos; Sonia de Avila Botton; Rudi Weiblen; Marvin J Grubman
The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response.
Journal of virology 2006;80(4):1906-14.
2005: Marvin J Grubman
Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Biologicals : journal of the International Association of Biological Standardization 2005;33(4):227-34.
2005: Juan M Pacheco; Mario C S Brum; Mauro P Moraes; William T Golde; Marvin J Grubman
Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine.
Virology 2005;337(2):205-9.
2005: Teresa de los Santos; Qiaohua Wu; Sonia de Avila Botton; Marvin J Grubman
Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus.
Virology 2005;335(2):222-31.
2005: Elida M Bautista; Geoffrey S Ferman; Douglas Gregg; Mario C S Brum; Marvin J Grubman; William T Golde
Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus.
Journal of virology 2005;79(8):4838-47.
2005: Marvin J Grubman; Teresa de los Santos
Rapid control of foot-and-mouth disease outbreaks: is RNAi a possible solution?
Trends in immunology 2005;26(2):65-8.
2004: Marvin J Grubman; Barry Baxt
Foot-and-mouth disease.
Clinical microbiology reviews 2004;17(2):465-93.
2003: Mauro P Moraes; Jarasvech Chinsangaram; Mario C S Brum; Marvin J Grubman
Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
Vaccine 2003;22(2):268-79.
2003: Marvin J Grubman
New approaches to rapidly control foot-and-mouth disease outbreaks.
Expert review of anti-infective therapy 2003;1(4):579-86.
2003: Qiaohua Wu; Mario C S Brum; Luizinho Caron; Marla Koster; Marvin J Grubman
Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2003;23(7):359-68.
2003: Qiaohua Wu; Mauro P Moraes; Marvin J Grubman
Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
Virus research 2003;93(2):211-9.
2003: Peter W Mason; Jarasvech Chinsangaram; Mauro P Moraes; GA Mayr; Marvin J Grubman
Engineering better vaccines for foot-and-mouth disease.
Developments in biologicals 2003;114():79-88.
2003: Peter W Mason; Marvin J Grubman; Barry Baxt
Molecular basis of pathogenesis of FMDV.
Virus research 2003;91(1):9-32.
2003: Jarasvech Chinsangaram; Mauro P Moraes; Marla Koster; Marvin J Grubman
Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease.
Journal of virology 2003;77(2):1621-5.
2002: Marvin J Grubman; Peter W Mason
Prospects, including time-frames, for improved foot and mouth disease vaccines.
Revue scientifique et technique (International Office of Epizootics) 2002;21(3):589-600.
2002: Mauro P Moraes; GA Mayr; Peter W Mason; Marvin J Grubman
Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.
Vaccine 2002;20(11-12):1631-9.
2001: Mauro P Moraes; GA Mayr; Marvin J Grubman
pAd5-Blue: direct ligation system for engineering recombinant adenovirus constructs.
BioTechniques 2001;31(5):1050, 1052, 1054-6.
2001: Jarasvech Chinsangaram; Marla Koster; Marvin J Grubman
Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase.
Journal of virology 2001;75(12):5498-503.
2001: Peter W Mason; Marvin J Grubman
Controlling foot-and-mouth disease with vaccines?
Australian veterinary journal 2001;79(5):342-3.
2001: GA Mayr; Vivian K O'Donnell; Jarasvech Chinsangaram; Peter W Mason; Marvin J Grubman
Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs.
Vaccine 2001;19(15-16):2152-62.
2000: Corrie C Brown; Jarasvech Chinsangaram; Marvin J Grubman
Type I interferon production in cattle infected with 2 strains of foot-and-mouth disease virus, as determined by in situ hybridization.
Canadian journal of veterinary research = Revue canadienne de recherche vétérinaire 2000;64(2):130-3.
1999: Jarasvech Chinsangaram; M E Piccone; Marvin J Grubman
Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon.
Journal of virology 1999;73(12):9891-8.
1999: GA Mayr; Jarasvech Chinsangaram; Marvin J Grubman
Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Virology 1999;263(2):496-506.
1999: C Beard; G Ward; Elizabeth Rieder; Jarasvech Chinsangaram; Marvin J Grubman; Peter W Mason
Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine.
Journal of biotechnology 1999;73(2-3):243-9.
1999: Jaroslava Halper; Marvin J Grubman; K L Jacobsen
Development of chicken antibodies to bovine interferon alpha.
Immunological investigations 1999;28(1):19-27.
1998: Jarasvech Chinsangaram; Peter W Mason; Marvin J Grubman
Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus.
Vaccine 1998;16(16):1516-22.
1998: M R Almeida; Elizabeth Rieder; Jarasvech Chinsangaram; G Ward; C Beard; Marvin J Grubman; Peter W Mason
Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus.
Virus research 1998;55(1):49-60.
1998: Jarasvech Chinsangaram; C Beard; Peter W Mason; M K Zellner; G Ward; Marvin J Grubman
Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.
Journal of virology 1998;72(5):4454-7.
1997: Peter W Mason; M E Piccone; T S Mckenna; Jarasvech Chinsangaram; Marvin J Grubman
Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate.
Virology 1997;227(1):96-102.
1996: M E Piccone; H H Chen; R P Roos; Marvin J Grubman
Construction of a chimeric Theiler's murine encephalomyelitis virus containing the leader gene of foot-and-mouth disease virus.
Virology 1996;226(1):135-9.
1996: Corrie C Brown; M E Piccone; P W Mason; T S McKenna; Marvin J Grubman
Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle.
Journal of virology 1996;70(8):5638-41.
1996: Corrie C Brown; J C Rhyan; Marvin J Grubman; L A Wilbur
Distribution of bluetongue virus in tissues of experimentally infected pregnant dogs as determined by in situ hybridization.
Veterinary pathology 1996;33(3):337-40.
1995: Marvin J Grubman; M Zellner; G Bablanian; P W Mason; M E Piccone
Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus.
Virology 1995;213(2):581-9.
1995: M E Piccone; Elizabeth Rieder; P W Mason; Marvin J Grubman
The foot-and-mouth disease virus leader proteinase gene is not required for viral replication.
Journal of virology 1995;69(9):5376-82.
1995: M E Piccone; M Zellner; T F Kumosinski; P W Mason; Marvin J Grubman
Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus.
Journal of virology 1995;69(8):4950-6.
1995: M E Piccone; S Sira; M Zellner; Marvin J Grubman
Expression in Escherichia coli and purification of biologically active L proteinase of foot-and-mouth disease virus.
Virus research 1995;35(3):263-75.
1994: Corrie C Brown; R F Meyer; Marvin J Grubman
Presence of African horse sickness virus in equine tissues, as determined by in situ hybridization.
Veterinary pathology 1994;31(6):689-94.
1994: R O de Sá; M Zellner; Marvin J Grubman
Phylogenetic analysis of segment 10 from African horsesickness virus and cognate genes from other orbiviruses.
Virus research 1994;33(2):157-65.
1994: Corrie C Brown; R F Meyer; Marvin J Grubman
Identification of African horse sickness virus in cell culture using a digoxigenin-labeled RNA probe.
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 1994;6(2):153-5.
1993: G M Bablanian; Marvin J Grubman
Characterization of the foot-and-mouth disease virus 3C protease expressed in Escherichia coli.
Virology 1993;197(1):320-7.
1993: Corrie C Brown; R F Meyer; Marvin J Grubman
Use of a digoxigenin-labeled RNA probe to detect all 24 serotypes of bluetongue virus in cell culture.
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 1993;5(2):159-62.
1992: L G Kleina; Marvin J Grubman
Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus.
Journal of virology 1992;66(12):7168-75.
1992: Marvin J Grubman; S A Lewis
Identification and characterization of the structural and nonstructural proteins of African horsesickness virus and determination of the genome coding assignments.
Virology 1992;186(2):444-51.
1991: S A Lewis; D O Morgan; Marvin J Grubman
Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs.
Journal of virology 1991;65(12):6572-80.
1991: S A Lewis; Marvin J Grubman
VP2 is the major exposed protein on orbiviruses.
Archives of virology 1991;121(1-4):233-6.
1990: S A Lewis; Marvin J Grubman
Bluetongue virus: surface exposure of VP7.
Virus research 1990;16(1):17-26.
1990: Marvin J Grubman; M Zellner; Siba K. Samal
Nucleotide and deduced amino acid sequence of the nonstructural phosphoprotein, NS2, of bluetongue virus serotype 17: comparison to two isolates of serotype 10.
Virus research 1990;15(3):243-50.
1989: Marvin J Grubman; Siba K. Samal
Nucleotide and deduced amino acid sequence of the nonstructural protein, NS1, of the US bluetongue virus serotype 17.
Nucleic acids research 1989;17(24):10498.
1988: M A Devaney; V N Vakharia; R E Lloyd; Ellie Ehrenfeld; Marvin J Grubman
Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex.
Journal of virology 1988;62(11):4407-9.
1988: R E Lloyd; Marvin J Grubman; Ellie Ehrenfeld
Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing.
Journal of virology 1988;62(11):4216-23.
1988: M A Devaney; J Kendall; Marvin J Grubman
Characterization of a nonstructural phosphoprotein of two orbiviruses.
Virus research 1988;11(2):151-64.
1987: V N Vakharia; M A Devaney; D M Moore; J J Dunn; Marvin J Grubman
Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts.
Journal of virology 1987;61(10):3199-207.
1987: Marvin J Grubman; M Zellner; J Wagner
Antigenic comparison of the polypeptides of foot-and-mouth disease virus serotypes and other picornaviruses.
Virology 1987;158(1):133-40.
1985: Marvin J Grubman; D O Morgan; J Kendall; B Baxt
Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells.
Journal of virology 1985;56(1):120-6.
1985: B H Robertson; Marvin J Grubman; G N Weddell; D M Moore; J D Welsh; T Fischer; D J Dowbenko; D G Yansura; B Small; D G Kleid
Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12.
Journal of virology 1985;54(3):651-60.
1985: G N Weddell; D G Yansura; D J Dowbenko; Maureen Hoatlin; Marvin J Grubman; D M Moore; D G Kleid
Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(9):2618-22.
1985: C H Campbell; Marvin J Grubman
Current knowledge on the biochemistry and immunology of bluetongue.
Progress in veterinary microbiology and immunology 1985;1():58-79.
1984: Marvin J Grubman; B H Robertson; D O Morgan; D M Moore; D Dowbenko
Biochemical map of polypeptides specified by foot-and-mouth disease virus.
Journal of virology 1984;50(2):579-86.
1983: B H Robertson; D O Morgan; D M Moore; Marvin J Grubman; J Card; T Fischer; G Weddell; D Dowbenko; D Yansura
Identification of amino acid and nucleotide sequence of the foot-and-mouth disease virus RNA polymerase.
Virology 1983;126(2):614-23.
1983: B H Robertson; D M Moore; Marvin J Grubman; D G Kleid
Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus.
Journal of virology 1983;46(1):311-6.
1982: Marvin J Grubman; B Baxt
Translation of foot-and-mouth disease virion RNA and processing of the primary cleavage products in a rabbit reticulocyte lysate.
Virology 1982;116(1):19-30.
1981: D G Kleid; D Yansura; B Small; D Dowbenko; D M Moore; Marvin J Grubman; P D McKercher; D O Morgan; B H Robertson; H L Bachrach
Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine.
Science (New York, N.Y.) 1981;214(4525):1125-9.
1981: Marvin J Grubman; B Baxt; J L La Torre; H L Bachrach
Identification of a protein kinase activity in purified foot- and-mouth disease virus.
Journal of virology 1981;39(2):455-62.
1980: J L La Torre; Marvin J Grubman; B Baxt; H L Bachrach
The structural polypeptides of aphthovirus are phosphoproteins.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(12):7444-7.